Trials / Completed
CompletedNCT02694445
Monetary Cost of Alzheimer's Disease in China
Monetary Cost of Alzheimer's Disease in China: Study Protocol for a Cluster Randomized Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,098 (actual)
- Sponsor
- Beijing Friendship Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to estimate the Chinese economic burden in patients with Alzheimer's Disease (AD).
Detailed description
This observational study covered all the 30 provincials/municipals/autonomous in mainland China except Hong Kong and Macau. Tier 3 hospitals, psychiatric hospitals, elderly hospitals, nursing home and communities were randomly selected as research centers, and more than 2500 patients with AD and their caregivers were enrolled at last. The main outcome of this study was assessed not only by the electronic medical system of communities and hospitals, but also by questionnaires. Using a societal prevalence-based gross COI approach to estimated the total yearly costs of AD in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | observation | The study is non-interventional. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-03-01
- Completion
- 2016-05-01
- First posted
- 2016-02-29
- Last updated
- 2020-05-12
- Results posted
- 2020-05-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02694445. Inclusion in this directory is not an endorsement.